Major Analyst Actions For Healthcare Stocks - istockAnalyst.com (press release)
Tue, 19 Jul 2011 23:18Amgen Inc. (AMGN): Amgen manufactures biopharmaceutical products and is the largest independent biotechnology company globally. The company's target stock price was recently cut by a dollar by UBS AG, and the firm reiterated its Neutral rating on the ...
Investing 101: Rallying Stocks Under $5 Undervalued to Analyst Estimates - Business Insider
Mon, 18 Jul 2011 23:34BioSante Pharmaceuticals, Inc. (BPAX): Biotechnology Industry. Market cap of $340.70M. The stock is currently trading 14.46% above its SAM20, 22.88% above its SMA50, and 68.38% above its SMA200. Current price at $3.45 vs. target price at $5.8. ...
Karen A. Dawes Elected as Repligen Co-chairperson of the Board of Directors - MarketWatch (press release)
Fri, 15 Jul 2011 13:24Ms. Dawes has held numerous executive level positions including Senior Vice President and US Business Group Head for Bayer Corporation's US Pharmaceuticals Group, Senior Vice President, Global Strategic Marketing for Wyeth, Vice President, ...
Billionaire Seth Klarman's 6 New Biotech and Gold Stocks - Seeking Alpha
Tue, 19 Jul 2011 18:03For every $100 increase in the price of gold, 30% could be added to the share price. With gold at all time highs of around $1600 an ounce the prospects look exciting. Competitors include US Gold (USG), who is reporting losses but has potential in ...
Novartis: A Common Sense Approach to Biotech - Seeking Alpha
Tue, 12 Jul 2011 19:49If your goal is to make money in pharmaceuticals, then buy a few shares of Novartis. Our fair value calculation is $88.97. If your goal is to win the lottery but you won't buy a ticket, then take a flyer on one of those 200 plus biotech companies that ...
Sector:
